Dr Konrad Rawlik is a Research Fellow and Data Curation Project Analyst at The University of Edinburgh’s Roslin Institute and one of the key people behind Omecu, a disruptive commercial platform which will change how genomic, and other medical data is accessed. He is co-founder of Omecu, a disruptive commercial platform which will change how genomic, and other medical data are accessed. His expertise has contributed to the development of a set of specially designed algorithms that cut the time it takes to analyse millions of genetic records from days to seconds. Dr Konrad Rawlik: embracing challenges Konrad Rawlik is a Research Fellow at The University of Edinburgh’s Roslin Institute and one of the key people behind Omecu, a disruptive commercial platform which will change how genomic, and other medical data are accessed. The company draws on three years of research conducted by Konrad and his colleague, Dr Oriol Canela-Xandri within the group of Professor Albert Tenesa. Creating a paradigm shift Scientists at the University of Edinburgh have launched Omecu Ltd, a spinout company that aims to democratise genetic data access and cut from days to minutes the time it takes to analyse millions of genetic records. Ten questions with Dr Konrad Rawlik Ten questions with Dr Konrad Rawlik This article was published on 2024-07-01
